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Abstract 
Introduction: Ischemic stroke or cerebral infarction is the main pathology among severe 
forms of vascular lesions of the brain. One of the more effective non-medicamental 
methods of treatment is pharmacological preconditioning. Pharmacological 
neuroprotection is one of the treatment areas to reduce the damage in ischemic stroke and 
other modifications of brain ischemia. Therefore, the development and introduction of new 
pharmacological agents that can reduce the degree of ischemic-reperfusion injury of the 
brain, remains one of the major challenges of modern medicine. The most promising to 
explore, from our point of view, is a PDE-5 inhibitor. 
Goal: Improving the efficiency of pharmacological cerebroprotective with 
pharmacological preconditioning of the PDE-5 inhibitor (tadalafil) in comparison with 
recombinant erythropoietin («Epocrin») and a neuroprotectant "Gliatilin". 
Materials and methods: In the pilot study used an integrated approach to the study of 
neuroprotective effects of pharmacological preconditioning in animals with ischemia-
reperfusion brain damage in four-vascular total ischemia of the brain. In the complex of 
methods included evaluation of neurological deficit, behavioral status, level of markers of 
brain damage S100b and NSE, morphometry. To compare the efficacy of tadalafil  
(1 mg/kg) in the experiment used recombinant erythropoietin «Epocrin» (50 IU/kg) and the 
neuroprotectant "Gliatilin" (85.7 mg/kg).  
Results and discussion: Prophylactic intraperitoneal administration of PDE-5 inhibitor, 
tadalafil (1 mg/kg) exerted cerebroprotective effect in modeling of ischemia-reperfusion, 
expressed in reducing the severity of neurological deficit (0.8±0.21 points), compared with 
the control group (of 2.05±0.49 points); increase in the number of stands at 1.7 times and 
2.2 hanging times; not a big increase in overall activity, patterns of movement, maximum 
speed, total distance increased 1.5 times, decrease rest time by 1.2 times; the reduction in 
the concentration of damage markers S100b 3.5 times and the NSE in 2 times. A number 
of distinctive characteristics the morphometric study, as well as a set of symptoms, 
manifestations of behavioral reactions confirm the fact of cerebroprotective properties of 
tadalafil in comparison with the control group animals.  
Conclusions: the conducted research showed cerebroprotective property of an inhibitor of 
phosphodiesterase type 5, tadalafil. The results of the study clearly indicate the prospects 
of its use in vascular pathology of the brain. 
Key words: pharmacological preconditioning, ischemia of the brain, tadalafil. 
 
Introduction 
Ischemic stroke or cerebral infarction is the 
main pathology among severe forms of vascular 
lesions of the brain [1, 2]. In Russia, this pathology 
ranks first as the cause of disability, and in the 
structure of total mortality is second [3]. The 
problem of timely pathogenetic treatment of this 
pathology is crucial due to the widespread 
prevalence, high mortality, disability and social 
exclusion suffered its patients [4]. To date, there are 
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two approaches to solve this problem: the use of 
medication (pharmacological) medications and 
non-pharmacological methods affecting the 
mobilization of domestic genetically-determined 
protective mechanisms, evolutionary acquired. 
With therapy achieves the restoration of blood flow 
in the ischemic region. Such therapies include: the 
destruction of blood clots, anticoagulant and 
antiplatelet therapy and hemodilution (using low 
molecular weight dextrans). To date, there is a need 
for search and development of new effective 
cerebroprotectors that could improve the course of 
disease, prevent the development of 
neurodegenerative processes in the brain, it is more 
useful to provide emergency assistance, reduce 
mortality, reduce the duration of the acute period, to 
reduce the disabling effects of the disease. One of 
the more effective non-medicamental methods is 
pharmacological preconditioning [5, 6]. 
Pharmacological neuroprotection is one of the 
treatment areas to reduce the damage in ischemic 
stroke and other modifications of brain ischemia. 
Therefore, the development and introduction of new 
pharmacological agents that can reduce the degree 
of ischemic-reperfusion injury of the brain, remains 
one of the major challenges of modern medicine. 
The most promising to explore, from our point of 
view, is a PDE-5 inhibitor. 
Currently in the neuro emergency care 
requires a constant introduction of new methods 
for the early detection and prevention of 
secondary damaging factors, including and 
stroke. The latest guidelines of American Heart 
Association / American Stroke Association and 
the Institute of cerebrovascular pathology and 
stroke are not the proposed methods of predicting 
the course of AI. According to a leading 
international clinical recommendations on the 
treatment and prevention of the consequences of 
stroke and to data obtained by the majority of 
large randomized trials to study the efficacy of 
cerebroprotective drugs, there was no 
neuroprotective regimen of drugs, which showed 
significant improvement of outcome of stroke. 
Now known for a large number of mechanisms 
that forms the basis preconditioning: open 
launcher agents, substances – mediators, a 
number of final targets [5, 6, 7]. One of the many 
branches of the study of agents that have a 
pharmacological preconditioning is the impact on 
the path of NO – cGMP – protein kinase G (PK – 
G) [8]. Recently, a new potential therapeutic 
strategy for inhibitor of phosphodiesterase type 5 
that it has a protective effect on the brain 
neurogenic, neurodegenerative diseases and 
memory loss [9, 10, 11]. Currently, no drugs 
based on iPDE – 5 approved for clinical use in 
stroke, therefore, it seems appropriate to study the 
presence of cerebroprotective properties of iPDE 
– 5 and their effectiveness. 
Goal: Improving the efficiency of 
pharmacological cerebroprotective with 
pharmacological preconditioning of the PDE-5 
inhibitor (tadalafil) in comparison with 
recombinant erythropoietin («Epocrin») and a 
neuroprotectant "Gliatilin". 
Materials and methods 
The study was performed on 410 
weinbrenner adult male rats line "Wistar" 5-6 
months of age weighing 220-250 g. the animals 
comply with all the rules of good laboratory 
practice in preclinical studies in Russia. Animals 
were kept under standard conditions, 
corresponding to sanitary regulations (No. 1045-
73), approved by the USSR health Ministry 
06.04.73 on the device, equipment and 
maintenance of experimental biological clinics 
(vivariums) and GOST R 53434-2009. 
Vivisection was carried out according to ethical 
principles for the treatment of laboratory animals 
"of the European Convention for the Protection of 
Vertebral Animals Used for Experimental and 
Other Scientific Purposes. CETS No.123". 
Methods of research in vivo. All the 
experiments were performed in accordance with 
methodological recommendations on preclinical 
study of drugs for treatment of disorders of cerebral 
circulation and migraine [1, 4]. In this study we used 
several methods reproduce the experimental models 
of cerebral ischemia: the "two-vascular " and " four-
vascular ". Ischemic stroke ischemic was simulated 
by a temporary occlusion of two common carotid 
arteries with subsequent reperfusion or by 
coagulation of two vertebral carotid artery with 
temporary occlusion of two common carotid 
arteries with subsequent reperfusion. Depending on 
the purpose of the study the duration of episodes of 
ischemia-reperfusion can vary [12]. Evaluation of 
adequacy of implementation of occlusion of the 
arteries supplying the brain, was carried out using 
the recording of the electrical activity of the brain of 
the animal and the level of microcirculation in the 
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sclera of the eye using laser Doppler flowmetry on 
the device Biopac Systems Inc. MP150 EEG100C 
and LDF 100C. The methods were implemented 
using the software AcqKnowledge 4.2. The 
criterion for correct execution of the techniques was 
the reduction of EEG amplitude and a decrease in 
the level of the microcirculation [13, 14, 15]. To 
assess the neurological status of rats used several 
methods:  
1. Point scale of evaluation of the McGraw 
stroke in the modification of I. V. Gannushkina 
[13, 16]. Within the group of rats with signs of 
neurological deficit were divided into animals 
with mild, moderate and severe symptoms of 
neurological deficit. If the animal has several 
signs of neurological deficit, the scores are 
summed.  
2. "Elevated cross maze" behavioral test to 
examine the activity, emotional state and level of 
anxiety in laboratory animals during the 
experiment [17]. In the experiment, was used to 
install the labyrinth of the firm Panlab Harvard 
Apparaturs LE 846.  
3. "Infrared activity monitor" – IR Actimeter 
allows you to test arbitrary locomotor activity, 
numbers and duration of episodes of getting up on 
his hind legs, stereotypical movements and 
exploratory behavior in the model of "perforated 
field" in terms of day and night illumination [17]. 
Is used to assess exploratory behavior. Were used 
in the experiment installation firm Panlab 
Harvard Apparaturs LE 8825. 
Methods in vitro. For more accurate results 
and correct interpretation of animal plasma is 
examined for two markers of brain damage – 
S100b and NSE. Determined by their 
concentration in the serum [18]. Morphometric 
study of histological [19, 20, 21] of brain slices 
was performed under a microscope MIKMED-6 
(LOMO, Russia). The Protocol of the study. 
Justification of doses. At the beginning of the 
experiment, all animals were randomized 
according to the degree of resistance to hypoxia. 
The experiment involved animals with average 
resistance. Under the objectives of the study, we 
have developed a model of pathology. For this 
simulated local two-vascular IGM group of rats (n 
= 10) and total IGM four-vascular group of rats (n 
= 10). As the comparison drugs used recombinant 
erythropoietin «Epocrin» and neuroprotectant 
"Gliatilin". Tadalafil (Eli Lilly Vostok S. A., 
Switzerland) were administered once 
intragastrically at a dose of 1 mg/kg for 60 min prior 
to the ischemia simulation. The selected dose 
corresponds to an average therapeutic dose for 
humans calculated by the formula interspecies 
transfer [8]. «Epocrin» – recombinant 
erythropoietin (FGUP GosNII OCHB, Saint-
Petersburg, Russia) was administered once at a dose 
of 50 IU/kg intraperitoneally 30 minutes before the 
modeling of the IGM. The dose chosen in order to 
avoid stimulation of erythropoiesis and the presence 
of the protective effect is proven in many organs and 
tissues [22, 23, 24, 25, 26, 27]. "Gliatilin" 
(ITALFARMACO, S. p.A. Italy) was injected once 
intragastrically at a dose of 85.7 mg/kg in the first 
case, for 30 min prior to simulation of ischemia, the 
second after 30 min after. The selected dose 
corresponds to the dose calculated by the formula 
interspecies transfer of doses. Glibenclamide is a 
blocker of ATP-sensitive potassium channels 
("Maninil", Berlin-Chemie AG), was injected once 
intragastrically at a dose of 5 mg/kg over 60 min. 
before simulation of the IGM [29]. 
The study Protocol included the following 
stages: modeling cerebral ischemia; evaluation of 
the level of the electroencephalogram of an 
animal and microcirculation by LDF; assessment 
of behavioral status (2 d) and neurological deficits 
at 1, 3, 7 and 14 days after modelling pathology; 
determining the presence of specific markers of 
brain damage S100b and NSE; removal of 
animals from the experiment and the taking of 
material for morphometric studies, analysis of 
blood for the presence of markers of brain damage 
S100bи NSE. In the Protocol of study of 
protective action of iPDE -5, EPO and "Gliatilin" 
included the following groups of animals (each 
group 10 animals): 
1. The group of intact animals. 
2. The group of false-operated animals. 
3. Group two-vascular model 4-min. 
4. Group four-vascular model 3-min. 
5. Group four-vascular model 4-min. 
6. Group four-vascular model for 4,5-min. 
7. Group four-vascular model 4-min + iFDE-
5. 
8. Group four-vascular model 4-min + EPO. 
9. Group four-vascular model 4-min + 
"Gliatilin" (СI).  
10. Group four-vascular model 4-min 
+"Gliatilin" (after СI).  
11. Group four-vascular model 4-min + 
iFDE-5+ "Gliatilin". 
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12. Group glib + iFDE-5 + four-vascular 
model 4-min. 
13. Group glib+ EPO + four-vascular model 
4-min. 
For all of the data was used descriptive 
statistics. The received data is checked for 
normality of distribution. Using the Shapiro-Wilk 
test have chosen the type of distribution. In the 
case of the normal distribution was calculated the 
average value M and standard error of the mean 
m. In cases of abnormal distribution were 
calculated median and quartile Me the scope of 
QR. Intergroup differences were analyzed by 
parametric (student's t-test) or nonparametric 
(Mann-Whitney test) methods, depending on the 
distribution type. Differences were determined at 
0,05 level of significance. Statistical analysis was 
performed using software Statistica 10.0 [30, 32, 
33]. 
Results and discussion 
In the beginning of the experiment was 
developed a set of methods for quantitative 
evaluation of disorders in ischemic-reperfusion 
brain injury, as described earlier. The true 
criterion of the performed techniques was to 
reduce the amplitude of the EEG and the level of 
microcirculation in the sclera of the eye by LDF. 
Also was selected as the optimal model of 
pathology – four-vascular and experimentally 
matched the duration of the ischemic period of 4 
min. This model of pathology was characterized 
by the development of neurological deficits (of 
2.05±0.49 points); reduction of the number of 
racks in 2 times and hanging 2.7 times roll 
"Elevated cross maze"; violation of behavioral 
status in the test of actimetry, which was 
manifested in the decline in overall activity in 2 
times, reducing the number of patterns of 
movement in 2 times, reduce the maximum speed 
by 1.5 times, decrease of passing the total distance 
of 2.3 times the increase in leisure time in 1.7 
times; the increase in the concentration of damage 
markers S100b 2.5 times and the NSE in 2 times; 
morphological changes: the presence of 90% 
hyperchromic neurons in the frontal lobes and the 
hippocampus. Depending on the research method 
for the control data received intact or false-
operated animals. 
Cerebroprotective effects of PDE-5 
inhibitor, tadalafil. Neurological deficit in rats on 
the background correction pharmacological 
preconditioning tadalafil (1 mg/kg) was more 
mild symptoms compared to the group of animals 
with CI without drug administration. 3, 7, 14 days 
was still polutes right eye. In behavioral test, 
ECM group of rats with CI and correction 
tadalafil manifested itself more actively in 
comparison with the control group. When 
comparing the locomotor activity of animals in 
the control group with the group in the correction 
tadalafil in the test of actimetry for infrared 
activity monitor IR Actimeter the activity of rats 
with pre-administration of the drug is higher 
(figure 1). 
 
Fig. 1. Effect of tadalafil on indicators of activity of the animals in the modeling  
of cerebral ischemia (iFDE-5) 
When analyzing the level of S100b and NSE 
in animals of the group with CI, with a 
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preliminary correction tadalafil observed a 
decrease in the levels of markers of damage even 
below the level of the control group (figure 2). 
 
 
 
Fig. 2. Effect of tadalafil on the concentration of 
markers of brain damage in the plasma of animals 
in 3 days (S100b-g/l; NSE – ng/ml)  
(M ± m; n = 10).  Note – * p<0.05, # – p < 0.05 in 
relation to intact rats 
 
In brain slices of rats with a preliminary 
introduction tadalalafil observed: hyperchromia 
neurons in the frontal lobes 43.4% and in the area 
of the hippocampus 90%; hypochromia neurons 
in the frontal lobes of 43.4% (in the area of the 
hypochromic hippocampal neurons were absent); 
neurons with two ravines in the frontal lobes of 
13.2% and in the area of the hippocampus 10%. 
Also recorded pericellular and perivascular 
edema, hyperemia of the capillaries (figure 3). 
 
 
 
 
Fig. 3. Brain Slices rat СI and prior to the 
introduction of tadalafil  
A- the frontal lobe, X 400, hematoxylin+eosin;  
B – hippocampus X 400 Deposit. 
hematoxylin+eosin 
 
Cerebroprotective effects of recombinant 
erythropoietin «Epocrin». Neurological deficit in 
rats with pre-introduction "Epocrin" (50 IU/kg) 
were with mild symptoms, compared to control 
group animals. 3, 7, 14 day remained the floor 
ptosis right eye. In behavioral test, ECM group of 
rats with correction "Epocrin" proved to be active. 
When comparing the locomotor activity of 
animals in the control group with the group in the 
correction of "Apocrine" in the test of actimetry 
for infrared activity monitor IR Actimeter the 
activity of the rats with pre-infusion is much 
higher relative to the control group (figure 4). 
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Fig. 4. The Effect of recombinant erythropoietin («Epocrin») on indicators of activity of animals  
in modeling cerebral ischemia   
 
When analyzing the level of S100b and NSE 
in animals of the group with CI, with a 
preliminary introduction of "Epocrin" observed 
the decrease in the concentration of markers of 
damage below the level of intact animals (p > 
0.05) (figure 5). 
 
 
 
Fig. 5. Effect of recombinant erythropoietin 
(«Epocrin») on markers of brain damage in the 
plasma of animals in 3 days (S100b-g/l;  
NSE – ng/ml) (M ± m; n = 10). 
Note – * p<0.05, # – p < 0.05 in relation  
to intact rats 
In brain slices of rats with a pre-introduction 
"Epocrine" was also observed by hyperchromia 
neurons is 43.3% in the frontal lobes and 69.7% in 
the area of the hippocampus; neurons hypochromia 
– 43.4% in the frontal lobes and 20.3% in the area 
of the hippocampus; neurons with two ravines 
neurons and 13.3% in the frontal lobes and 10% in 
the area of the hippocampus. Also recorded 
pericellular and perivascular edema, hyperemia of 
the capillaries (figure 6). 
 
 
 
Fig. 6. Brain Slices rat IGM and prior to the 
introduction of "Epocrin":  
A – frontal lobe, X 400, hematoxylin+eosin; 
B – hippocampus X 400 Deposit. hematoxylin+eosin 
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Cerebroprotective effects of the 
neuroprotectant "Gliatilin". Neurological deficit 
of the groups of rats as a prophylactic and 
therapeutic introduction "Gliatilin" (85.7 mg/kg) 
was with a medium degree of gravity. 3, 7, 14 
days was preserved paralysis of hind left limb and 
remained the floor ptosis, ptosis of the right eye. 
The group of rats with the introduction of the drug 
for medicinal purposes in the modeling of the 
pathology observed the same symptoms of 
neurological deficit except Manege movements. 
Visually the activity of rats in these experimental 
groups did not differ from the control group as in 
the test ECM and test altimetry (figure 7). 
 
Fig. 7. Influence of neuroprotectant "Gliatilin" on indicators of activity  
of animals in modeling cerebral ischemia 
 
The level of S100b and NSE in the animals 
of group a prophylactic introduction of "Gliatilin" 
above the level of the control group. The level of 
markers of damage a group of rats with a 
therapeutic drug is lower than in the control group 
(figure 8). 
  
Fig. 8. Influence of neuroprotectant "Gliatilin" markers of brain damage in the plasma of animals in 3 
days (S100b-µg/l; NSE – ng/ml) (M ± m; n = 10).  
Note – * – p<0.05, # – p < 0.05 in relation to intact rats 
 
In brain slices of rats in the correction of 
"Gliatilin" both preventive and therapeutic 
purposes observed: hyperchromia neurons were 
92% and 88% in the frontal lobes, 89% and 84% 
in the area of the hippocampus; neurons 
hypochromia – 8% and 12% in the frontal lobes, 
in the area of the hypochromic hippocampal 
neurons were absent; neurons with two ravines 
neurons in the frontal lobes absent, in the area of 
the hippocampus, their number corresponded to 
11% and 16%. Also recorded pericellular and 
perivascular edema, hyperemia of the capillaries 
(figures 9, 10). 
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Fig. 9. Brain Slices of a rat a prophylactic 
introduction of "Gliatilin":  
A – frontal lobe, X 400, hematoxylin+eosin; 
 B – hippocampus X 400,. hematoxylin+eosin 
 
Fig. 10. Brain Slices of the rat with a medical 
introduction of the "Gliatilin":  
A – frontal lobe, X 400, hematoxylin+eosin;  
B – hippocampus, X 400, hematoxylin+eosin 
 
 
Additive effect of combined use of PDE-5 
inhibitor, tadalafil and neuroprotectant 
"Gliatilin". Neurological deficit in rats, "iFDE-
5+CI+Gliatilin" (1 mg/kg; 85,7 mg/kg) were with 
mild symptoms. 3, 7, 14 days was preserved the 
floor ptosis right eye. In behavioral test, ECM 
group of rats", iFDE-5+CI+Gliatilin" were active, 
compared with the group СI. Compared with 
groups of rats in monotherapy, this group has a 
significantly greater activity. Locomotor activity 
of rats ", iFDE-5+СI+Gliatilin" in the test of 
actimetry for infrared activity monitor IR 
Actimeter higher than in rats with BL a group of 
rats in monotherapy (figure 11). 
 
 
Fig. 11. The Effect of combination of tadalafil (iPDE -5)and neuroprotectant "Gliatilin" on indicators  
of activity of animals in modeling cerebral ischemia 
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When analyzing the level of S100b and NSE in 
the animals of group " iPDE -5+IGM+Gliatilin" 
observed the decrease in the concentration of 
markers of damage below the level of intact animals 
(p > 0.05) (figure 12).  
 
 
 
 
Fig. 12. Effect of combination of tadalafil 
(iPDE-5) and neuroprotectant "Gliatilin" markers 
of brain damage in the plasma of animals in 3 
days (S100b-g/l; NSE – ng/ml) (M ± m; n =10). 
Note – * p<0.05, # – p < 0.05 in relation  
to intact rats 
 
In brain slices of rats ", iFDE-
5+CI+Gliatilin" observed: hyperchromia neurons 
and 32% in the frontal lobes and 70% in the area 
of the hippocampus; hypochromia neurons is 
54.8% in the frontal lobes and 15% in the area of 
the hippocampus; neurons with two ravines 
neurons of 13.2% in the frontal lobes and 15% in 
the area of the hippocampus. Also recorded 
pericellular and perivascular edema, hyperemia of 
the capillaries (figure 13). 
 
Fig. 13. The brain Slices of the rat group  
"iPDE-5+IGM+Gliatilin": 
A – frontal lobe, X 400, hematoxylin+eosin; 
 B – hippocampus, X 400, hematoxylin+eosin 
 
 
The contribution of K+ATP-channels to the 
implementation of the cerebroprotective effects 
of pharmacological preconditioning. 
Neurological deficit in animal groups "Glib + 
iFDE-5 + CI" and "Gleb + EPO + CI" (5 mg/kg) 
were medium severity, which was not statistically 
different from the group with only IGM. 3, 7, 14 
days was preserved paralysis of left rear leg and 
the floor ptosis /ptosis of the right eye. In the 
behavioral test ECM behavior of groups of rats 
"Glib + iFDE-5 + CI", "Glib + EPO + CI" was 
characterized by decreased horizontal activity, a 
significant reduction in vertical activity. The 
activity of rats between these experimental groups 
are similar, which confirms the cancellation 
preconditioning properties of drugs due to prior 
administration of blocker of K+ATP channels 
(figure 14). 
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Fig. 14. Effect of tadalafil (iPDE-5), "Epocrin" with the prior introduction of glibenclamid on the activity  
of animals in modeling cerebral ischemia 
 
When analyzing the level of S100b and NSE in 
the animals of group "Glib + iFDE-5 + CI" and "Glib 
+ EPO + CI" was observed by increasing the 
concentration of markers of damage. Their 
concentration is statistically significantly different 
from concentration intimnyh rats (p < 0.05)  
(figure 15). 
 
 
  
 
Fig. 15. Effect of tadalafil (iPDE-5), "Epocrin" with the prior introduction of glibenclamid on the 
concentration of markers of brain damage in the plasma of animals in 3 days (S100b-g/l; NSE – ng/ml) 
(M ± m; n =10). 
Note – * p<0.05, # – p < 0.05 in relation to intact rats 
 
Histological preparations of the brain of rats 
of the group "Glib + EPO + CI" similar to the 
preparations of the group "Glib + iFDE-5 + CI". 
These groups were observed scattered neurons, 
the neurons hyperchromia to 83.6% and 70% in 
the frontal lobes, 63.4% and 80% in the area of 
the hippocampus; hypochromia neurons to 10% 
and 20% in the frontal lobes, 26.6% and 10% in 
the area of the hippocampus; neurons with two 
ravines neurons in the frontal lobes absent, in the 
area of the hippocampus, their number 
corresponded to 10% and 10%. Also recorded 
pericellular and perivascular edema, hyperemia of 
the capillaries.  
Based on the measurements obtained after 
morphometric studies and examination of brain 
slices, it is clear that glibenclamid preconditioners 
cancels the action of tadalafil and recombinant 
erythropoietin (figures 16, 17). 
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Fig. 16. Brain Slices of the rat group "Glib 
+iFDE-5+ CI": 
A – frontal lobe, X 400, env. hematoxylin+eosin;  
B – hippocampus, X 400, env. hematoxylin+eosin 
 
 
Fig. 17. Brain Slices of the rat group "Glib 
+EPO+ CI": 
A – frontal lobe, X 400, hematoxylin+eosin;  
B – hippocampus, X 400,  hematoxylin+eosin 
In the result of the study was chosen as the 
optimal model to study four-vascular model  
4-minute ischemia of the brain with the 
justification of a temporary simulation mode.  
A single administration of tadalafil  
(1 mg/kg) and "Epocrin" (50 IU/kg) led to rapid 
recovery of EEG amplitude after the ischemic 
period, preserving the electrophysiological 
activity of the retina, improve behavioral status, 
reducing the level of neurological deficit, markers 
of brain damage S100b and NSE, to increase the 
number of hypochromic and presence of two 
nuclei in neuron in histological sections of brain. 
Prophylactic administration of a 
neuroprotectant "Gliatilin" (85.7 mg/kg) did not 
produce positive results. The performance of rats 
in this group did not differ from indicators of 
control CI (p > 0.05).  
Concomitant use of prophylactic 
administration of tadalafil (1 mg/kg) and 
neuroprotectant "Gliatilin" (85.7 mg/kg) has an 
additive cerebroprotective effect, which is 
manifested in the improvement of all criteria for 
the integrated assessment of this pathology. 
Prior administration of glibenclamid  
(5 mg/kg) neutralized the positive effects tadalafil 
(1 mg/kg) and "Epocrin" (50 IU/kg) ischemic 
preconditioning, confirming the implementation 
of cerebroprotective by preconditioning, with the 
participation of ATP-sensitive potassium 
channels. 
For visualization of the obtained data was 
constructed charts on indicators of behavioral 
status and neurological deficits of the animals (as 
a percentage) calculated area of each shape, and 
dynamics of changes in markers of brain damage 
(figure 18-23). The smaller the area of the figure 
of the group, the harder the degree of ischemia of 
the rat brain (figure 23). 
 
Martynova O.V. Tadalafil as an agent of pharmacological preconditioning in ischemic – 
reperfusion brain injury. Research result: pharmacology and clinical pharmacology.  
2017;3(3):20-36. 
31 
 
September. 2017. 3(3). Res Result Pharmacol Clin Pharmacol. rrpharmacology.ru 
 
Fig. 18. Impact of duration and severity of the ischemic episode on the indicators of activity of 
animals in the experiment 
 
 
Fig. 19. Influence of used drugs on the activity rate of animals with cerebral ischemia 
 
 
Fig. 20. Influence of used drugs on the activity rate of animals with cerebral ischemia 
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Fig. 21. Influence of used drugs on the duration of stay of animals in the test of actimetry 
 
 
 
Fig. 22. Influence of used drugs on the level of specific markers of damage of the rat brain S100b and 
NSE 
 
 
 Martynova O.V. Tadalafil as an agent of pharmacological preconditioning in ischemic – 
reperfusion brain injury. Research result: pharmacology and clinical pharmacology. 
2017;3(3):20-36. 
33 
 
September. 2017. 3(3). Res Result Pharmacol Clin Pharmacol. rrpharmacology.ru  
 
 
Fig. 23. Area values radar chart of the experimental groups 
 
The received results convincingly testify to 
the long term development of pharmacological 
methods and approaches of correction of ischemic 
brain injury based on triggering mechanism of 
pharmacological preconditioning. To do this, but 
recombinant erythropoietin can be used inhibitor 
of phosphodiesterase type 5. 
Conclusions 
1. Four-vascular model the 4-minute model 
of brain pathology in rats was characterized by the 
development of neurological deficits (of 
2.05±0.49 points); a decrease in the number of 
racks in 2 times and hanging 2.7 times roll 
"Elevated cross maze"; violation of behavioral 
status in the test of actimetry, which was 
manifested in the decline in overall activity in 2 
times, reducing the number of patterns of 
movement in 2 times, reduce the maximum speed 
by 1.5 times, decrease of passing the total distance 
of 2.3 times the increase in leisure time is 1.7 
times; the increase in the concentration of damage 
markers S100b 2.5 times and the NSE in 2 times; 
morphological changes: the presence of 90% 
hyperchromic neurons in the frontal lobes and the 
hippocampus. 
2. Prophylactic intraperitoneal administration 
(60 min) of PDE-5 inhibitor, tadalafil (1 mg/kg) 
exerted cerebroprotective effect in modeling of 
ischemia-reperfusion, expressed in reducing the 
severity of neurological deficit (0.8±0.21 points), 
compared with the control group (of 2.05±0.49 
points); increase in the number of stands at 1.7 times 
and 2.2 hanging times; not a big increase in overall 
activity, patterns of movement, maximum speed, 
total distance increased 1.5 times, decrease rest time 
by 1.2 times; the reduction in the concentration of 
damage markers S100b 3.5 times and the NSE in 2 
times. A number of distinctive characteristics the 
morphometric study, as well as a set of symptoms, 
manifestations of behavioral reactions confirm the 
fact of cerebroprotective properties of tadalafil in 
comparison with the control group animals.  
3. Prophylactic intraperitoneal administration 
of recombinant erythropoietin «Epocrin» (50 
IU/kg) exerted cerebroprotective effect in modeling 
of ischemia-reperfusion, expressed in reducing the 
severity of neurological deficit (0.8±0.21 points) 
compared with the control group (of 2.05±0.49 
points); increase in the number of racks and hanging 
2 times; not a big increase in overall activity, 
patterns of movement, maximum velocity, an 
increase in the total distance of 1.7 times, reduction 
of time of stay 1.2 times; the reduction in the 
concentration of damage markers S100b in 3.3 
times and the NSE in 2 times. Morphometry 
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confirmed the neuroprotection "Epocrin" the brain 
of the rats. 
4. The use of intraperitoneal prophylactic 
neuroprotectant "Gliatilin" (85.7 mg/kg) had a weak 
cerebroprotective action, which is expressed in the 
acceleration of recovery of neurological deficit 
(2.0±0.46 points); no significant increase in the 
number of racks and hanging, overall activity, 
patterns of movement, maximum speed, total 
distance and decrease rest time; not a significant 
prevention of the increase of the values of neuron 
specific enolase and protein S100b in the blood 
serum. Therapeutic use "Gliatilin" (85.7 mg/kg) 
exerted a more pronounced cerebroprotective action 
compared to the prophylactic administration of the 
drug, which is manifested in the acceleration of 
recovery of neurological deficit (1.75±0.13 points) 
and locomotor activity compared with the effects of 
prophylactic purpose. Morphometry in the 
application of "Gliatilin" as in prophylactic and 
therapeutic purposes show a lower neuroprotective 
response in comparison with tadalafil. 
5. Concomitant use of prophylactic 
administration of tadalafil (1 mg/kg) and 
neuroprotectant "Gliatilin" (85.7 mg/kg) has an 
additive cerebroprotective action, which is 
expressed in the presence of mild neurological 
deficit (0.55±0.07 points); increase in the number 
of racks in 2 times and hanging 2.6 times; an 
increase in overall activity and patterns of 
movement by 1.5 times, the maximum speed of 
1.4 times, an increase in the total distance in 2 
times, decrease rest time to 1.5 times; 
approximation of values of neuron specific 
enolase and protein S100b in the blood serum to 
indicators of intact animals. Morphometry of 
combined use of tadalafil (1 mg/kg) and 
neuroprotectant "Gliatilin" (85.7 mg/kg) 
significantly increase the resistance of rat brain to 
ischemia-reperfusion injury compared with the 
monotherapy.  
6. Blockade of K+ATP- channels 
glibenclamid (5 mg/kg) removes the effects of 
pharmacological preconditioning of the PDE-5 
inhibitor and tadalafil does not affect 
neuroprotection mediated "Gliatilin". 
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